Pre-Phase Chemotherapy Followed By Ofatumumab (OFA) and Reduced Dose CHOP (OFA-mini-CHOP) for Patients over 80 Years with Diffuse Large B-Cell Lymphoma (DLBCL) – a Lymphoma Study Association (LYSA) Prospective Phase II Study (LNH09-7B)

@inproceedings{Peyrade2014PrePhaseCF,
  title={Pre-Phase Chemotherapy Followed By Ofatumumab (OFA) and Reduced Dose CHOP (OFA-mini-CHOP) for Patients over 80 Years with Diffuse Large B-Cell Lymphoma (DLBCL) – a Lymphoma Study Association (LYSA) Prospective Phase II Study (LNH09-7B)},
  author={Fr{\'e}d{\'e}ric Peyrade and Bologna Serge and V Delwail and Jean-François Emile and Christian Rose and Christophe Ferm{\'e} and Jean-Marc Schiano and Bertrand Coiffier and Bernadette Corront and Hassan Farhat and Christophe Fruchart and Herv{\'e} Ghesqui{\`e}res and Margaret Macro and Herv{\'e} Tilly and Bachra Choufi and Richard Delarue and Olivier Fitoussi and Jean Gabarre and Corinne Haioun and Fabrice Jardin},
  year={2014}
}

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-2 OF 2 CITATIONS

Similar Papers

Loading similar papers…